LQLY — Qly Biotech Income Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsHighly SpeculativeMicro Cap
Annual income statement for Qly Biotech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.004 | 0.004 | 0 |
| Cost of Revenue | ||||
| Gross Profit | — | 0.003 | 0.003 | 0 |
| Selling / General / Administrative Expenses | ||||
| Total Operating Expenses | 0.001 | 0.009 | 0.034 | 0.014 |
| Operating Profit | -0.001 | -0.005 | -0.029 | -0.014 |
| Net Income Before Taxes | -0.001 | -0.005 | -0.029 | -0.014 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.001 | -0.005 | -0.029 | -0.014 |
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -0.001 | -0.005 | -0.029 | -0.014 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.001 | -0.005 | -0.029 | -0.014 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0 | -0.002 | -0.008 | -0.004 |
| Dividends per Share |